Treatment of Advanced Hepatocellular Carcinoma after Failure of Sorafenib Treatment: Subsequent or Additional Treatment Interventions Contribute to Prolonged Survival Postprogression

BACKGROUND: Sorafenib is a first-line treatment option for advanced hepatocellular carcinoma (HCC) patients; however, survival predictors upon progression have not been well characterized. In the present study, we aimed to show the efficacy of multidisciplinary therapy for patients who had failed to...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Gastroenterol Res Pract
Main Authors: Kondo, Masaaki, Numata, Kazushi, Hara, Koji, Nozaki, Akito, Fukuda, Hiroyuki, Chuma, Makoto, Maeda, Shin, Tanaka, Katsuaki
Format: Artigo
Sprog:Inglês
Udgivet: Hindawi 2017
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5498900/
https://ncbi.nlm.nih.gov/pubmed/28717362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/5728946
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker